Retatrutide

Disclaimer

Products supplied by SYNA Labs Ltd are intended strictly for laboratory and scientific research purposes only. They are not medicines, are not approved for human or veterinary use, and must not be used to diagnose, treat, cure, or prevent any disease or medical condition. Products are not for human or animal consumption, cosmetic, food, or recreational use. By purchasing from SYNA Labs Ltd, customers confirm they are qualified individuals or entities purchasing solely for legitimate research purposes and agree to our Terms and Conditions and Research Use Policy.

As a multi-receptor agonist, Retatrutide has been engineered to interact with several peptide hormone receptor systems simultaneously, positioning it as a useful tool for laboratory research into metabolic pathway regulation and receptor-mediated signalling. Its design supports detailed study of how multiple receptor systems coordinate within broader endocrine signalling networks.

Within biochemical and cellular research settings, Retatrutide is applied to examine how it engages multiple receptor pathways and influences downstream intracellular signalling. It allows researchers to investigate receptor activation, signal transduction, and peptide-receptor binding dynamics, with results shaped by factors such as concentration, exposure duration, assay design, and the experimental model in use.

Product: Retatrutide 20mg

Synonyms / Designations: Retatrutide, LY3437943, Triple Receptor Agonist Peptide
CAS Number: 2381089-83-2
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: 4731.33 g/mol
Peptide Type: Synthetic Multi-Receptor Agonist Peptide
Purity: ≥99% (HPLC)
Appearance: White to off-white lyophilised powder
Pack Size: 20 mg
Storage: Desiccated, protected from light, stored at –20°C or below
Solubility: Soluble in water and buffered aqueous solutions.

Applications in Research

• Investigation of peptide hormone receptor signalling pathways.
• Studies examining receptor activation and intracellular signal transduction.
• Evaluation of multi-receptor agonist activity in cellular research models.
• Analysis of peptide-receptor binding characteristics and receptor selectivity.
• Use as a reference compound in endocrine, metabolic, and signalling pathway research.
• Mechanistic studies involving receptor-mediated cellular responses.

Specifications Summary

Handling, Reconstitution & Stability

• Handle under dry conditions to minimise moisture exposure.
• Reconstitute using sterile water or an appropriate buffered aqueous solution according to experimental requirements.
• Avoid vigorous agitation during dissolution.
• Filter sterilize if needed (e.g. 0.22 µm) immediately prior to use.
• Aliquot reconstituted solutions prior to storage to minimise degradation.
• Store reconstituted solutions at –20 °C (or lower) and avoid repeated freeze–thaw cycles.

Precautions & Notes

• Experimental behaviour may vary according to receptor expression levels, peptide concentration, and exposure conditions; appropriate positive and negative controls are recommended.
• Buffer composition, pH, and ionic strength may influence peptide stability and performance.
• Protect from prolonged exposure to light, moisture, and elevated temperatures.
• Experimental results should be interpreted within the context of the specific assay system employed.
• Retatrutide is intended exclusively for laboratory research and analytical applications. For research use only — not for human consumption, therapeutic use, diagnostic procedures, performance enhancement, or veterinary applications.